Rigel Pharma (RIGL) Receives Milestone Payment as Part of Cancer Treatment Collaboration

December 23, 2009 7:41 AM EST Send to a Friend
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) today announced that it has received a milestone payment from Daiichi Sankyo Co., Ltd. as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login